Delivery Order SPE2DB24D1205-SPE2DB25FCVAQ

Award Date 3/19/25
Potential Completion Date 3/20/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,547.00, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $10,889.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a period of performance through January 5, 2024. The contract is structured as a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $21,610.77, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, to support military healthcare programs. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,108.65, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The contract is a Firm Fixed Price Delivery Order with a completion date of March 7, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $6,347.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical commodity used in healthcare settings. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,666.66, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical devices. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,093.49, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,252.60, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The contract is a Delivery Order type with a Firm Fixed Price pricing structure and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,767.02, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $2,691.62, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCVAQ
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,065.71, is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 6/18/25, 11:10 AM